# Cardiovascular, Pulmonary, and Integrative Functional Phenotypes in COVID-19 Survivors - Effect of Fenofibrate

> **NCT05080192** · — · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 12 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Fenofibrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05080192
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-11
- **Primary completion:** 2022-05-10
- **Final completion:** 2022-05-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05080192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05080192, "Cardiovascular, Pulmonary, and Integrative Functional Phenotypes in COVID-19 Survivors - Effect of Fenofibrate". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05080192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*